<a href="https://www.fiercebiotech.com/medtech/artivion-nabs-pma-clearance-fda-aortic-stent-graft-system" hreflang="en">Artivion nabs PMA clearance for aortic stent graft system, triggers Endospan buyout option</a>

Artivion's recent pre-market approval (PMA) for its aortic stent graft system highlights a significant regulatory milestone that could position the company as a competitive player in the cardiac and vascular surgery sector. For someone tracking medtech and FDA approvals, this development signals a potential investment opportunity or partnership prospect, as PMA indicates a high standard of efficacy and safety, paving the way for market entry and adoption.